Seeing and Measuring Hepatobiliary Disease Using Artificial Intelligence, Presented by Perspectum at RSNA 2019
Perspectum will be showcasing the application of Artificial Intelligence in their FDA-cleared, quantitative imaging services ? LiverMultiScan for liver tissue characterization and MRCP+ for biliary tree visualization ? at RSNA's annual meeting this year.
Perspectum's co-founder, Professor Sir Michael Brady, will show how machine learning can be integrated with LiverMultiScan and MRCP+ to enhance disease detection with improved precision, and potentially monitor disease progression. A total of four abstracts highlighting the utility of Perspectum's technology will be presented at RSNA.
Details of the presentations are listed below:
Oral presentations
A Machine Learning Pipeline for Automatic Multi-Site-Vendor Quantitative MRI Analysis of the Liver | SSE09-01 | Monday, 3:00 PM ? 4:00 PM | Room N230B
Quantitative Biliary Tree Imaging by MRI: A Novel Method of Assessing Change Over Time in Hepatobiliary Disease via MRCP | SSG14-03 | Tuesday, 10:30 AM ? 12:00 PM | Room S504AB
Diagnosis of Pediatric Liver Diseases with Multiparametric MRI and Quantitative Magnetic Resonance Cholangiopancreatography (MRCP) Analysis | RC413-02 | Tuesday, 3:00 PM ? 6:00 PM | Room E353B
Poster presentation
Assessing the Accuracy, Reproducibility and Repeatability of Novel Quantitative Approach to MRCP Imaging | IN005-EB-SUB | Sunday 1:00 PM ? 1:30 PM | Learning Center
Quantitative biliary tree imaging with MRCP+ reveals differences between AIH and PSC patients (images above). PSC patients show a significant increase in biliary tree strictures and dilatations between baseline and 1-year follow up, which is not observed in AIH patients.
"Monitoring progression of this unpredictable disease remains a major challenge for clinicians managing PSC patients. By objectively quantifying changes in the bile ducts, MRCP+ yields additional information to conventional MRCP. PSC Support is encouraged by this technology and we hope that it can help to reduce uncertainty for patients." ? Martine Walmsley, PSC Support
Visit Perspectum at booth #10112 in the AI showcase to find out more. To reserve a meeting or connect with the team, visit www.perspectum.com/contact
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...
Summary
Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV"). Approval for the delisting was received at...
L.A. Care Health Plan and Blue Shield of California Promise Health Plan today held a grand opening ceremony for their Community Resource Center (CRC) in West Los Angeles (West L.A.) at 11173 W. Pico Blvd in Los Angeles....
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered...